The UK's Department of Health last week pledged up to £100 million ($148 million) to sequence the genomes of 100,000 patients over the next five years, with an immediate focus on lung and pediatric cancers, and rare and infectious diseases.

Dubbed the 100K Genomes Project, the effort will be coordinated through Genomics England, a company the DH established in April to handle contracts for specialist UK-based companies, universities and hospitals that will supply sequencing, data linkage, and analysis services.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.